Skip Main Links
Prescribing Information
Important Safety Information
For Healthcare
Providers

Discover XYWAV

Patient speaking to a doctor with an elephant (made of salt) in the room

Discover XYWAV

For Narcolepsy

XYWAV can help treat cataplexy and/or
excessive daytime sleepiness (EDS).

LEARN MORE

For Idiopathic
Hypersomnia (IH)

XYWAV is the first and only
FDA‑approved treatment for adults with IH.

XYWAV oral solution, 0.5 g/mL total salts (equivalent to 0.413 g/mL of oxybate) is the only FDA‑approved treatment for cataplexy and/or excessive daytime sleepiness in narcolepsy and for idiopathic hypersomnia (IH) in adults.

XYWAV oral solution, 0.5 g/mL total salts (equivalent to 0.413 g/mL of oxybate) is the only
FDA‑approved treatment for cataplexy and/or excessive daytime sleepiness in narcolepsy and for idiopathic hypersomnia (IH) in adults.

Up Arrow Icon

This site is intended for US residents only.

© 2024 Jazz Pharmaceuticals, Inc. US-XYW-2200416 Rev1124